BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 9, 2018
View Archived Issues
FDA accepts SIGA Technologies' NDA for TPOXX
Read More
Daiichi Sankyo studies DS-1205c with osimertinib for metastatic or unresectable EGFR-mutant NSCLC
Read More
New phase II umbrella trial studies novel agents for the management of relapsed ovarian cancer
Read More
V ClinBio acquires 49.98% equity stake in Cellix Bio
Read More
Rebinyn launched in the U.S.for the treatment of hemophilia B
Read More
Sanofi files tender offer for Bioverativ
Read More
Columbia University divulges novel CKI-epsilon inhibitors
Read More
Q Biomed receives exclusive option for glaucoma biomarker GDF-15
Read More
FDA priority review granted for antimalarial tafenoquine
Read More
New RET kinase inhibitors identified at Blueprint Medicines
Read More
Roche discovers new serine protease HTRA1 inhibitors
Read More
Shanghai Yingli Pharmaceutical presents new TGF-beta receptor type-1 inhibitors
Read More
Novel ACKR3 antagonists patented by Idorsia Pharmaceuticals
Read More
Therapix Biosciences clarifies regulatory pathway for THX-110
Read More
ABAC Therapeutics identifies novel antibacterials
Read More
AstraZeneca announces pipeline highlights of fourth quarter 2017
Read More
SPK-8011 shown safe and effective for hemophilia A
Read More
GlaxoSmithKline reviews milestones of fourth quarter 2017
Read More
Implantable device allows photodynamic therapy for tumors deep in the body
Read More
Vifor prepares to begin phase I trial of oral ferroportin inhibitor VIT-2763
Read More
Significant reductions in LDL-cholesterol seen with MGL-3196 in phase II tiral
Read More
uniQure presents further clinical data on AMT-060 for hemophilia B
Read More
Rexahn Pharmaceuticals to collaborate with Zhejiang Haichang Biotechnology on RX-0201
Read More
Lonza Pharma & Biotech and Denali Therapeutics partner on biologics
Read More
Bristol-Myers Squibb offers overview of fourth quarter 2017
Read More
FDA grants orphan drug designation to Xeris' ready-to-use, liquid-stable glucagon
Read More
Phase III trials of peficitinib in rheumatoid arthritis meet primary endpoints
Read More
Fujifilm and Takeda establish regenerative medicine collaboration to treat heart failure
Read More
Treatment begins in phase II SHINE-1 study of scar reduction with EB-001
Read More
FDA approves Zytiga with prednisone for metastatic high-risk castration-sensitive prostate cancer
Read More